Paul Ariagno
Neurology · Pigeon, MINPI 1891742144
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.0% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for neurology clinicians in MI, where the typical reported total is $1,115.
Across 83 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$322
- Pfizer$139
- Biogen$130
- Novartis$115
- Neurocrine Biosciences, Inc.$99
- UCB, Inc.$66
- plus $486 from 14 others
What the payments were for
- Speaking & faculty fees$232%
- Food & beverage$1,27594%
- Education$594%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 29 | $322 |
| Pfizer | 8 | $139 |
| Biogen | 10 | $130 |
| Novartis | 6 | $115 |
| Neurocrine Biosciences, Inc. | 4 | $99 |
| UCB, Inc. | 3 | $66 |
| Genentech USA, Inc. | 3 | $62 |
| EMD Serono, Inc. | 2 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Acadia Pharmaceuticals Inc | 2 | $47 |
| Tanabe Pharma America, Inc. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 3 | $40 |
| AstraZeneca | 2 | $39 |
| MDD US Operations, LLC | 1 | $31 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Acorda Therapeutics, Inc | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Lundbeck LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| Bristol Myers Squibb | 1 | $14 |
How this compares
$1,357 in reported general payments places this provider in the 50th percentile of 652 neurology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 66 | $1,258 |
| Gabapentin | 31 | $339 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 19 | $210 |
| Baclofen | 13 | $198 |
| Propranolol Hcl | 12 | $196 |
| Duloxetine Hcl | 20 | $194 |
| Levetiracetam | 11 | $160 |
| Divalproex Sodium | 12 | $150 |
| Donepezil Hcl | 14 | $102 |
| Lamotrigine | 11 | $65 |
Paid to pharmacies, not to this prescriber.
Other neurology in Pigeon
- Aaron EllenbogenFarmington Hills$1.6M
- Matthew HoltzmanWayne$1.4M
- Richard TroschFarmington Hills$1.2M
- Wade CooperAnn Arbor$991K
- Bisena BulicaDetroit$900K
- Julie BurnhamMount Clemens$836K
- Amit MasihOkemos$785K
- Martin BelkinFarmington Hills$712K
- Robert PaceOwosso$693K
- Rosemarie WalchOwosso$563K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.